Mechanism of Action of Anakinra
Introduction Anakinra is a recombinant human interleukin‑1 receptor antagonist (IL‑1Ra) used to treat rheumatoid arthritis, neonatal-onset multisystem inflammatory disease (NOMID), and other autoinflammatory conditions. It competitively inhibits IL‑1α and IL‑1β binding to IL‑1 receptors, effectively reducing inflammation. Step-by-Step Mechanism of Action Pharmacokinetic Parameters Parameter Value Route Subcutaneous injection (daily) Bioavailability ~95% Time to Peak (Tmax) … Read more